375 related articles for article (PubMed ID: 30843876)
1. BAFF-driven B cell hyperplasia underlies lung disease in common variable immunodeficiency.
Maglione PJ; Gyimesi G; Cols M; Radigan L; Ko HM; Weinberger T; Lee BH; Grasset EK; Rahman AH; Cerutti A; Cunningham-Rundles C
JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30843876
[TBL] [Abstract][Full Text] [Related]
2. B Cell Dysregulation in Common Variable Immunodeficiency Interstitial Lung Disease.
Matson EM; Abyazi ML; Bell KA; Hayes KM; Maglione PJ
Front Immunol; 2020; 11():622114. PubMed ID: 33613556
[TBL] [Abstract][Full Text] [Related]
3. Bronchoalveolar Lavage Fluid Reflects a T
Friedmann D; Unger S; Keller B; Rakhmanov M; Goldacker S; Zissel G; Frye BC; Schupp JC; Prasse A; Warnatz K
Front Immunol; 2020; 11():616832. PubMed ID: 33613543
[TBL] [Abstract][Full Text] [Related]
4. Tertiary lymphoid neogenesis is a component of pulmonary lymphoid hyperplasia in patients with common variable immunodeficiency.
Maglione PJ; Ko HM; Beasley MB; Strauchen JA; Cunningham-Rundles C
J Allergy Clin Immunol; 2014 Feb; 133(2):535-42. PubMed ID: 24131823
[TBL] [Abstract][Full Text] [Related]
5. Increased serum concentration of BAFF/APRIL and IgA2 subclass in patients with mixed connective tissue disease complicated by interstitial lung disease.
Kaneko T; Amano H; Kawano S; Minowa K; Ando S; Watanabe T; Nakano S; Suzuki J; Morimoto S; Tokano Y; Takasaki Y
Mod Rheumatol; 2014 Mar; 24(2):310-5. PubMed ID: 24252051
[TBL] [Abstract][Full Text] [Related]
6. Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency (CVID): A Multicenter Retrospective Study of Patients From Italian PID Referral Centers.
Cinetto F; Scarpa R; Carrabba M; Firinu D; Lougaris V; Buso H; Garzi G; Gianese S; Soccodato V; Punziano A; Lagnese G; Tessarin G; Costanzo G; Landini N; Vio S; Bondioni MP; Consonni D; Marasco C; Del Giacco S; Rattazzi M; Vacca A; Plebani A; Fabio G; Spadaro G; Agostini C; Quinti I; Milito C
Front Immunol; 2021; 12():627423. PubMed ID: 33777011
[No Abstract] [Full Text] [Related]
7. Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung disease.
Hamada T; Samukawa T; Kumamoto T; Hatanaka K; Tsukuya G; Yamamoto M; Machida K; Watanabe M; Mizuno K; Higashimoto I; Inoue Y; Inoue H
BMC Pulm Med; 2015 Sep; 15():110. PubMed ID: 26424433
[TBL] [Abstract][Full Text] [Related]
8. Histology of Interstitial Lung Disease in Common Variable Immune Deficiency.
Dhalla F; Lochlainn DJM; Chapel H; Patel SY
Front Immunol; 2020; 11():605187. PubMed ID: 33329602
[TBL] [Abstract][Full Text] [Related]
9. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency.
Barbosa RR; Silva SL; Silva SP; Melo AC; Pereira-Santos MC; Barata JT; Hammarström L; Cascalho M; Sousa AE
J Clin Immunol; 2014 Jul; 34(5):573-83. PubMed ID: 24809296
[TBL] [Abstract][Full Text] [Related]
10. Interstitial lung disease in patients with common variable immunodeficiency disorders: several different pathologies?
Patel S; Anzilotti C; Lucas M; Moore N; Chapel H
Clin Exp Immunol; 2019 Nov; 198(2):212-223. PubMed ID: 31216049
[TBL] [Abstract][Full Text] [Related]
11. Interstitial Lung Disease in Common Variable Immunodeficiency.
Lopes JP; Ho HE; Cunningham-Rundles C
Front Immunol; 2021; 12():605945. PubMed ID: 33776995
[TBL] [Abstract][Full Text] [Related]
12. Rituximab Monotherapy for Common Variable Immune Deficiency-Associated Granulomatous-Lymphocytic Interstitial Lung Disease.
Ng J; Wright K; Alvarez M; Hunninghake GM; Wesemann DR
Chest; 2019 May; 155(5):e117-e121. PubMed ID: 31060706
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum B-cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease.
Matsushita T; Kobayashi T; Kano M; Hamaguchi Y; Takehara K
J Dermatol; 2019 Dec; 46(12):1190-1196. PubMed ID: 31631384
[TBL] [Abstract][Full Text] [Related]
14. Increased Serum B Cell Activating Factor and a Proliferation-inducing Ligand Are Associated with Interstitial Lung Disease in Patients with Juvenile Dermatomyositis.
Kobayashi N; Kobayashi I; Mori M; Sato S; Iwata N; Shigemura T; Agematsu K; Yokota S; Koike K
J Rheumatol; 2015 Dec; 42(12):2412-8. PubMed ID: 26472413
[TBL] [Abstract][Full Text] [Related]
15. Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency.
Verbsky JW; Hintermeyer MK; Simpson PM; Feng M; Barbeau J; Rao N; Cool CD; Sosa-Lozano LA; Baruah D; Hammelev E; Busalacchi A; Rymaszewski A; Woodliff J; Chen S; Bausch-Jurken M; Routes JM
J Allergy Clin Immunol; 2021 Feb; 147(2):704-712.e17. PubMed ID: 32745555
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary radiologic findings in common variable immunodeficiency: clinical and immunological correlations.
Maglione PJ; Overbey JR; Radigan L; Bagiella E; Cunningham-Rundles C
Ann Allergy Asthma Immunol; 2014 Oct; 113(4):452-9. PubMed ID: 24880814
[TBL] [Abstract][Full Text] [Related]
17. Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency-Features of CT and
Fraz MSA; Moe N; Revheim ME; Stavrinou ML; Durheim MT; Nordøy I; Macpherson ME; Aukrust P; Jørgensen SF; Aaløkken TM; Fevang B
Front Immunol; 2020; 11():617985. PubMed ID: 33584710
[TBL] [Abstract][Full Text] [Related]
18. Factors Beyond Lack of Antibody Govern Pulmonary Complications in Primary Antibody Deficiency.
Weinberger T; Fuleihan R; Cunningham-Rundles C; Maglione PJ
J Clin Immunol; 2019 May; 39(4):440-447. PubMed ID: 31089938
[TBL] [Abstract][Full Text] [Related]
19. Role of B Cell-Activating Factor in Chronic Obstructive Pulmonary Disease.
Seys LJ; Verhamme FM; Schinwald A; Hammad H; Cunoosamy DM; Bantsimba-Malanda C; Sabirsh A; McCall E; Flavell L; Herbst R; Provoost S; Lambrecht BN; Joos GF; Brusselle GG; Bracke KR
Am J Respir Crit Care Med; 2015 Sep; 192(6):706-18. PubMed ID: 26266827
[TBL] [Abstract][Full Text] [Related]
20. Rituximab Monotherapy Is Effective as First-Line Treatment for Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in CVID Patients.
Tessarin G; Baronio M; Gazzurelli L; Rossi S; Chiarini M; Moratto D; Giliani SC; Bondioni MP; Badolato R; Lougaris V
J Clin Immunol; 2023 Nov; 43(8):2091-2103. PubMed ID: 37755605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
